ALS drug trial pulled before it even started
Disease control
Terminated
This study aimed to see if a mist-inhaled drug called RNS60 could help people with ALS, a nerve disease that weakens muscles. It planned to measure changes in daily function, breathing, and survival. However, the trial was withdrawn before enrolling any participants, so no result…
Phase: PHASE2 • Sponsor: Revalesio Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC